title: Use of preclinical models to improve treatment of retinoblastoma.
authors.affiliation: Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America. michael.dyer@stjude.org
authors.forename: Michael A
authors.initials: MA
authors.lastname: Dyer
authors.forename: Carlos
authors.initials: C
authors.lastname: Rodriguez-Galindo
authors.forename: Matthew W
authors.initials: MW
authors.lastname: Wilson
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D016923:Cell Death; D049109:Cell Proliferation; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D006801:Humans; D051379:Mice; D010641:Phenotype; D019572:Retinal Neoplasms / Q000503:physiopathology* / Q000628:therapy*; D012175:Retinoblastoma / Q000503:physiopathology* / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents